Investing

Can Healthcare AI Pass the New Financial Reality Check?
Technology Can Healthcare AI Pass the New Financial Reality Check?

The era when a healthcare startup could secure a multi-million dollar pilot program based solely on the novelty of its machine learning algorithms has officially come to a close. Today, the medical technology landscape is undergoing a profound transformation, moving rapidly from a period of

FDA Approves Yuviwel for Weekly Treatment of Achondroplasia
Public Policy FDA Approves Yuviwel for Weekly Treatment of Achondroplasia

The recent authorization of Yuviwel by the FDA represents a transformative moment for thousands of families navigating the complexities of achondroplasia, effectively dismantling a long-standing market monopoly. For the first time, pediatric patients aged two and older with open growth plates have

Health Tech Firms Raise $700 Million for Specialized Care
Technology Health Tech Firms Raise $700 Million for Specialized Care

The landscape of digital medicine is undergoing a profound transformation as venture capital moves away from the broad "one-size-fits-all" telehealth models of the past toward highly calibrated, condition-specific clinical interventions. This recent influx of $700 million across five key

Namibia Mandates Public Healthcare for State Employees
Public Policy Namibia Mandates Public Healthcare for State Employees

The long-standing disparity between Namibian public and private medical facilities is currently facing its most significant legal and operational challenge as the state enforces a new era of mandatory public service utilization for its workforce. For decades, the country has operated under a

Why Is ZeOmega a Visionary in Payer Care Management?
Process Why Is ZeOmega a Visionary in Payer Care Management?

The traditional health insurance model of simply processing claims has been effectively replaced by a mandate for total member health ownership that requires a radical shift in digital infrastructure. Modern health plans no longer operate as passive financial intermediaries but instead act as

FDA Grants Full Approval to Pfizer for BRAFTOVI Combination
Public Policy FDA Grants Full Approval to Pfizer for BRAFTOVI Combination

The landscape of oncology has fundamentally shifted from a reliance on broad-spectrum toxicities toward the surgical precision of molecularly targeted interventions that exploit specific genetic vulnerabilities within tumor cells. This transition defines the current struggle against metastatic

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later